Lahon Kingshuk, Das Swarnamoni
Department of Pharmacology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India.
Pharmacognosy Res. 2011 Jan;3(1):13-8. doi: 10.4103/0974-8490.79110.
There is a lack of reliable hepatoprotective drugs in modern medicine to prevent and treat drug-induced liver damage. Leaves of Sacred/Holy Basil, i.e. Green Tulsi (Ocimum sanctum), belonging to family Lamiaceae are used traditionally for their hepatoprotective effect. We wanted to evaluate the hepatoprotective activity of Ocimum sanctum and observe whether synergistic hepatoprotection exists with silymarin.
Albino rats (150-200 g) were divided into five groups. Groups A and B were normal and experimental controls, respectively. Groups C, D and E received the alcoholic extract of Ocimum Sanctum leaves (OSE) 200 mg/kg BW/day, silymarin 100 mg/kg BW/day and OSE 100 mg/kg BW/day + silymarin 50 mg/kg BW/day p.o., respectively, for 10 days. Hepatotoxicity was induced in Groups B, C, D and E on the eighth day with paracetamol 2 g/kg BW/day. The hepatoprotective effect was evaluated by performing an assay of the serum proteins, albumin globulin ratio, alkaline phosphatase, transaminases and liver histopathology. The assay results were presented as mean and standard error of mean (SEM) for each group. The study group was compared with the control group by one-way ANOVA, followed by Bonferoni's test. A P-value of <0.01 was considered significant.
In groups C, D and E, liver enzymes and albumin globulin ratio were significantly (P < 0.01) closer to normal than in group B. Reduction in sinusoidal congestion, cloudy swelling and fatty changes and regenerative areas of the liver were observed on histopathological examination in groups C, D and E, whereas group B showed only hepatic necrosis.
The Ocimum sanctum alcoholic leaf extract shows significant hepatoprotective activity and synergism with silymarin.
现代医学中缺乏可靠的用于预防和治疗药物性肝损伤的保肝药物。唇形科植物圣罗勒,即绿叶图尔西(神圣罗勒)的叶子,传统上因其保肝作用而被使用。我们想要评估神圣罗勒的保肝活性,并观察其与水飞蓟宾是否存在协同保肝作用。
将白化病大鼠(150 - 200克)分为五组。A组和B组分别为正常对照组和实验对照组。C组、D组和E组分别口服神圣罗勒叶乙醇提取物(OSE)200毫克/千克体重/天、水飞蓟宾100毫克/千克体重/天以及OSE 100毫克/千克体重/天 + 水飞蓟宾50毫克/千克体重/天,持续10天。在第8天,B组、C组、D组和E组用对乙酰氨基酚2克/千克体重/天诱导肝毒性。通过检测血清蛋白、白蛋白球蛋白比值、碱性磷酸酶、转氨酶以及进行肝脏组织病理学检查来评估保肝效果。检测结果以每组的平均值和平均标准误差(SEM)表示。通过单因素方差分析将研究组与对照组进行比较,随后进行邦费罗尼检验。P值<0.01被认为具有显著性。
与B组相比,C组、D组和E组的肝酶和白蛋白球蛋白比值显著(P < 0.01)更接近正常水平。组织病理学检查显示,C组、D组和E组肝脏的窦状隙充血、浊肿和脂肪变性以及再生区域减少,而B组仅显示肝坏死。
神圣罗勒叶乙醇提取物显示出显著的保肝活性,并与水飞蓟宾具有协同作用。